
Medical Device R&D and Manufacturer
9Month9Day, Johnson & Johnson (NYSE:JNJ)Announced Important Personnel Changes, Elected John·Maurice (John Morikis) as a member of the board of directors.This move is expected to inject new momentum into Johnson & Johnson's pursuit of new development in a complex and ever-changing market environment.
Maurice had an outstanding career in the business field and retired last year from his position as Chairman, President, and Chief Executive Officer of Sherwin-Williams. As a global leader in the manufacture, development, distribution, and sale of paints, coatings, and related products, Sherwin-Williams achieved significant growth during Maurice's eight-year leadership.
Sherwin-Williams (Sherwin-Williams) was founded in1866Year,Headquartered in Cleveland, Ohio, USA, it is one of the oldest paint manufacturers in the world and currently the paint supplier with the highest market value globally.2023Annual Net Sales Reached230.5Billion USD, business coverage120Multiple countries and regions, with6.410,000 employees and5000Yu's self-operated store. Its products cover fields such as industrial wood, general industry, packaging, coil and profile, automotive, heavy industrial anti-corrosion, and marine coatings.2024Year11Month Included in Dow Jones Industrial Average, Replacing Dow Inc.。
Maurice1984Joined Sherwin-Williams as a management trainee of the paint store group, and over the following forty years, advanced through various positions, from department president, group president, to serving as...10President and Chief Operating Officer, eventually in2016Became the company's "leader" in year.Under his leadership, Sherwin-Williams achieved deep global business expansion, extending its reach to123countries. At the same time, the company actively optimizes the supply chain and heavily invests in technology, significantly enhancing customer experience and operational efficiency, successfully completing a strategic transformation. These achievements fully demonstrate Morikis's outstanding leadership and strategic vision.

John·Maurice
Alex Gorsky, Chairman and CEO of Johnson & Johnson(Joaquin Duato)A Warm Welcome and High Praise for Morikis' Joining. It was noted that Morikis is a well-tested leader in large multinational organizations, with a profound understanding of global markets and complex supply chains. During this critical period where Johnson & Johnson is committed to providing next-generation healthcare innovations for patients, Morikis’ unique perspective and ability to leverage technology to drive innovation will become an invaluable asset to the company. This indicates that Johnson & Johnson hopes to utilize Morikis’ experience to make breakthroughs in the field of healthcare innovation and enhance the company’s competitiveness in the global market.
Moulikis himself expressed his honor and anticipation in joining the Johnson & Johnson Board of Directors. He stated that he has long admired Johnson & Johnson's achievements in innovation, its leadership in the healthcare field, and its unwavering commitment to patients worldwide. He looks forward to collaborating closely with the management team and other board members to fully support Johnson & Johnson’s long-term strategy of delivering breakthrough treatments to patients and creating value for shareholders. This demonstrates Moulikis' confidence in the future development of Johnson & Johnson and his willingness to contribute to the company’s growth with his experience.
Johnson & Johnson's inclusion of Morikis on its board of directors marks a significant move in its talent strategy.This willBring new ideas and vitality to the company's innovative development, global business expansion, and supply chain optimization, thereby enhancing the company's overall performance and market value, and creating more returns for shareholders.

